Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

FSD Pharma, Inc., is a publicly traded holding company since May 2018.

FSD BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, FSD201, ultra-micronized palmitoylethanolamide (PEA). Ultra-micro PEA is known to target the CB2 receptors of the endocannabinoid system of the human body and acts by down-regulating the pro-inflammatory cytokines to effectuate an anti-inflammatory response.

The company has successfully completed Phase 1 first-in-human safety and tolerability study for FSD201 and has found the compound to be safe with no serious adverse side effects. This study also validated considerable scientific literature already published in the European Union that claims safety and tolerability of micro-PEA. Ultra-micro PEA is currently beings dispensed in Italy and Spain as a prescription based medical food supplement since 2004.

The company received permission from the Food and Drug Administration (FDA) on June 1, 2020 to submit an Investigational New Drug Application (IND) for the use of FSD201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.

Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and ultimately death. The Company is focused on developing FSD201 for its anti-inflammatory properties to avoid the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients.

 

Gaia Grow Corp. (the “Company”) is a licenced cultivator of industrial hemp. The Company’s business model leverages contract farming to utilize existing farmland and skilled farmers to cultivate industrial hemp, which it then sells to processors to be turned into hemp fibre and cannabidiol oil and concentrates. The Company expects to expand its operations to include retail cannabis stores in British Columbia.

Global Health Clinics operates a two-part system of customer lead generation and conversion, through its network of pavilions and the ownership and operation of five medical clinics that aim to connect Canadians with ACMPR license producers by advancing the understanding of medical cannabis and its applications, and the provision of related services and products for patients suffering from illness from which they may find relief with medical cannabis, including facilitating access to qualified health care practitioners, independent medical cannabis evaluations and related advice. Through its pavilions, the company is developing a substantive consumer database of persons interested in both medicinal and recreational use

Vodis Pharmaceuticals Inc. is a craft cannabis producer in Delta, British Columbia, Canada.  The company was issued a Standard Cultivation licence and Standard Processing licence under the Cannabis Act on January 31, 2020.  The company operates a 12,000 sqft indoor facility growing proprietary cultivars for the adult-use, recreational cannabis market.  At full capacity, the Delta facility will yield approximately 1,500 kg of craft cannabis annually.  

The Company is a lifestyle oriented, consumer products company that celebrates health, wellness and happiness.  We are in the business of cultivation, processing and retailing of cannabis, tetrahydrocannabidol, cannabidiol (“CBD”) and cannabis-infused consumer products.  Over the next 12 months, the Company intends to expand its retail and wholesale cannabis businesses as well as its CBD consumer products business through a combination of strategic partnerships, merger and acquisition activity, and organic license capture.  The Company’s objectives are to establish retail cannabis locations, or otherwise apply for such licenses, in various states within that timeframe, pursuant to state laws.  Such activity will focus on those certain states where cannabis has been legalized for medical and/or recreational use at the state level.

Each Warrant shall entitle the holders thereof to purchase common shares on the basis of one common share for each warrant upon payment of the Exercise Price of $3.50, subject to the terms of the indenture.

Green Growth Brands Inc. - Common Shares

 

 

 

Green Thumb Industries (GTI), a national cannabis consumer packaged goods company and retailer, is dedicated to providing dignified access to cannabis while giving back to the communities in which they serve. GTI manufactures and distributes a portfolio of branded cannabis products including Beboe, Dogwalkers, Dr. Solomon’s, incredibles, Rythm, and The Feel Collection. The Company also owns and operates a rapidly growing national chain of retail cannabis stores called Rise and, in the Las Vegas, Nevada area, a chain of stores called Essence, which both sell GTI and third-party products. Headquartered in Chicago, Illinois, GTI has 13 manufacturing facilities, licenses for 96 retail locations and operations across 12 U.S. markets. Established in 2014, GTI employs approximately 2,100 people and serves hundreds of thousands of patients and customers each year.

Investor Note: In addition to the 178,130,854 Subordinate Voting Shares that are listed and trading, there are 35,232,000 shares reserved specifically for issuance pursuant to the conversion rights attached to the Super Voting Shares and Multiple Voting Shares that are issued and outstanding but not listed.  The total number of equity shares assuming all are converted into the listed class would be 213,362,854.

 

Grown Rogue is a multi-state cannabis operator that was founded in the Emerald Triangle of Southern Oregon. The company prides itself on cultivating award-winning high quality and consistent flower that is sought after by leading retailers and consumers. The company is now bringing its expertise in facility development, indoor and outdoor production practices, supply chain, operations and sales to other states as it strategically expands to new markets.

The Issuer develops health and wellness supplements that contain CBD and other cannabinoids found in Industrial Hemp.

Harborside is, through its subsidiaries and controlled entities, both directly and indirectly engaged in the manufacture, possession, use, sale or distribution of cannabis in the recreational and/or medicinal cannabis marketplace in the State of California and the State of Oregon.

Investor Note: :

Investor Note: In addition to the 26,535,608 Subordinate Voting Shares that are listed and trading, there are 17,909,642 reserved for issuance pursuant to the conversion rights attached to the Multiple Voting Shares, that are issued and outstanding but not listed. The total number of issued shares assuming all are converted into the listed class would be 45,057,083.​

 

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Advertisement

Publicité